ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1

Study Overview
=================
Brief Summary
-----------------
The goal of this study is to learn about the patient and provider perceptions, priorities, preferences, and willingness to use/prescribe anticoagulation as a stroke prevention therapy in patients with atrial fibrillation. Qualitative interviews will be performed with atrial fibrillation patients and providers caring for atrial fibrillation patients. The investigators want to understand the factors that influence decision-making about anticoagulation medications, and to gain insight into patients' and providers' knowledge of the risk of stroke and bleeding associated with oral anticoagulation. This feedback will help provide better education to providers caring for patients with atrial fibrillation and better care to patients with atrial fibrillation by developing tools to optimize the appropriate use of oral anticoagulation for patients with atrial fibrillation.

Official Title
-----------------
ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1

Conditions
-----------------
Atrial Fibrillation

Participation Criteria
=================
Eligibility Criteria
-----------------
Patient Inclusion Criteria: adult patient age 18 or older; English speaking; diagnosed atrial fibrillation; at least 1 risk factor for congestive heart failure, hypertension, age, diabetes, stroke (CHADS2) or 2 risk factors for CHADS2 with vascular disease, age, and sex (CHADS2-VASc) ; no documented cognitive impairment per the medical record; not being prescribed an oral anticoagulant Provider Inclusion Criteria: 1. physician at one of the study sites treating patients diagnosed with atrial fibrillation Exclusion Criteria: None

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patients<br>Patients of consenting providers will complete a short survey and interview. | |
| Providers<br>Physicians treating patients with atrial fibrillation will complete a short survey and interview. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Perceptions of using anticoagulation as a stroke prevention therapy in atrial fibrillation, as measured by survey and interview | Each telephone interview (data collection time point) will be approximately one hour | one hour | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Willingness to use anticoagulation as a stroke prevention therapy in atrial fibrillation, as measured by survey and interview | Each telephone interview (data collection time point) will be approximately one hour | one hour | 
| preferences for using anticoagulation as a stroke prevention therapy in atrial fibrillation, as measured by survey and interview | Each telephone interview (data collection time point) will be approximately one hour | one hour | 
| priorities for using anticoagulation as a stroke prevention therapy in atrial fibrillation, as measured by survey and interview | Each telephone interview (data collection time point) will be approximately one hour | one hour | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
atrial fibrillation, anticoagulation